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Background/aim: H. pylori has been found to be related to certain dermatological diseases. However, there is no data as yet to propose
an association between H. pylori and pityriasis versicolor. In this study, we aimed to evaluate the association between H. pylori and
pityriasis versicolor.
Materials and methods: This was a prospective study performed in the Gastroenterology and Dermatology and Venereology
departments of the Health Sciences University, Ankara Training and Research Centre. A total of 57 consecutive patients (27 pityriasis
versicolor, 30 telogen effluvium) were enrolled from the Department of Dermatology and Venereology. All patients were screened for
H. pylori IgG and CagA. In addition, urea breath test was carried out to detect the existence of H. pylori infection.
Results: There were significantly higher rates of H. pylori positivity, H. pylori IgG in serum in the pityriasis versicolor group compared
to the telogen effluvium group (P < 0.05). In addition, the number of patients with dyspeptic complaints was higher in the pityriasis
versicolor group than in the telogen effluvium group. The odds ratio for dyspepsia, H. pylori positivity, and H. pylori IgG were 2.48,
1.67, and 1.78, respectively.
Conclusion: In this study, we found a statistically significant relationship between H. pylori infection and pityriasis versicolor. Therefore,
H. pylori eradication could be considered in recurrent pityriasis versicolor patients with dyspepsia. New studies are required to clarify
the effect of eradication treatment on the clinical course of pityriasis versicolor.
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1. Introduction
Helicobacter pylori is a bacterium in the gastric and
duodenal mucosa that causes dyspeptic symptoms and
gastric cancer [1]. H. pylori has been found to be related
to certain dermatological diseases such as chronic
spontaneous urticaria, atopic dermatitis, lichen planus,
and vitiligo [2,3].
Pityriasis versicolor (PV) also known as tinea versicolor
is a chronic, benign, and asymptomatic infection caused
by Malassezia spp. [4]. Hereditary factors, hyperhidrosis,
seborrhoea, and the chemical constitution of sebum may
play an important role in the aetiology of PV [5].
H. pylori-induced systemic inflammation has been
shown to play a role in the pathogenesis of skin diseases
such as chronic urticaria, and atopic dermatitis leading
to dysregulation of cytotoxic and other cell-mediated
mechanisms in the skin microenvironment [6]. This

immune dysregulation in the skin microenvironment
could provide the basis for the formation of pityriasis
versicolor (PV) in patients with H. pylori infection. The
aim of this research was to investigate the relationship of
H. pylori with skin diseases in patients with PV.
2. Materials and methods
2.1. Study population
This was a prospective study performed in the
Gastroenterology and Dermatology and Venereology
Departments of the Health Sciences University, Ankara
Training and Research Hospital. Twenty-seven consecutive
patients with PV were enrolled from the Department of
Dermatology and Venereology. The diagnosis of these
patients was done by clinical examination, Wood’s lamp,
and KOH examination. The control group consisted of 30
consecutive patients who presented to the Department of
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Dermatology and Venereology due to telogen effluvium
(TE). The TE group was described as patients who had
hair loss occurring 3 months after a triggering event and
increasing telogen hair over 20% in a trichogram. Since
there is no immunological basis for TE, the control group
was selected as those with TE. The diagnosis of patients
with PV and TE was performed by the department of
Dermatology and Venereology.
The presence of H. pylori was determined by H. pylori
IgG, H. pylori CagA, and urea breath test (UBT).
2.2. Antibody measurements
H. pylori IgG and H. pylori CagA were detected by Elisa
(Dia. PRO. Diagnostic Bioprobes Srl. Milano, Italy).
Samples with a concentration higher than 20 U/mL were
considered positive for H. pylori and 5 arbU/mL for anti
CagA.
2.3. C14 urea breath test
Urea breath test was conducted as follows: after a nighttime fast, the patients received a 14C-labelled ureacontaining drug (HelicapTM, Institute of Isotopes,
Budapest, Hungary) with 50 mL water. After 15 min, the
patients exhaled into a dry cartridge (Heliprobe breath
card, Kibion AB, Uppsala, Sweden) until the colour of the
card indicator changed from orange to yellow, which took
about 1–2 min. Finally, the test results were displayed on
at screen analyser that indicates radioactivity as counts
per minute (CPM). 50 CPM: patient infected. 25 CPM:
patient not infected; 25–50 CPM, borderline or suspicious
outcome. We considered <25 CPM as a negative result and
considered >50 CPM as a positive result.
Patients receiving proton pump inhibitor therapy for
the last 1 month, who had a history of H. pylori eradication,
who were smoking, drinking alcohol, who were pregnant,
who had a major psychiatric disorder, candidiasis and
being over-eager were excluded from this study. Patients
were interrogated for the presence of dyspeptic symptoms.
Dyspepsia was described as swelling, upper gastrointestinal
discomfort, regurgitation, premature sense of fullness and
heartburn. Ethical approval for this study was given by
the hospital ethics committees with 0558-13.08.14 and
informed written consent was acquired from all patients.
2.4. Statistical analysis
Chi-square test was used for categorical data differences
between the 2 groups. A P-value of <0.05 was considered
statistically significant. The odds ratio (OR) was obtained
to quantify the strength of the association between case
and control groups. All statistical analyses were performed
using SPSS 20 statistical package (IBM Corp., Armonk,
NY, USA).
3. Results
Ten patients were excluded from this study since they had
suspicious results in UBT. Fifty-seven patients (41 female,
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16 male patients) participated in the study. Twenty-seven
patients had PV while 30 patients had TE.
When the demographic characteristics of the patients
were evaluated, there was no significant differentiation
between the ages and body mass indexes of PV and control
groups. The Hb score in the TE group was statistically
lower than in the PV group (P < 0.05). There were no
differences between the 2 groups regarding socioeconomic
status and smoking habit. Demographic and laboratory
characteristics of the patients are shown in Table 1.
Dyspeptic complaints, H. pylori IgG, and UBT
positivity were found to be significantly higher in the
PV group than in the TE group (P < 0.05). However, no
significant differentiation was found between the 2 groups
in terms of H. pylori CagA antigen levels (P > 0.05). (Table
2). Odds ratio for dyspepsia, UBT, and H.pylori Ig G
positivity were 2.48, 1.67, and 1.78, respectively (Table 3).
4. Discussion
An increasing number of dermatologic diseases including
atopic dermatitis, aphthous stomatitis, rosacea, HenochSchoenlein purpura, alopecia areata, vitiligo, and psoriasis
have been associated with H. pylori infection since the
identification of H. pylori in 1983. In addition to its direct
injury to target tissues, H. pylori could use its destructive
effects indirectly by interfering with the immune system in
these diseases [7].
Chronic urticaria and immune thrombocytopenic
purpura are the skin diseases most associated with H.
pylori infection [8,9]. Of note, some studies suggested
that eradication of H. pylori is related to improvement
of skin diseases [10–12]. In this context, illumination
of the association between H. pylori infection and skin
diseases may contribute to the prevention or treatment
of these diseases. Although there are many studies on the
association between H. pylori infection and skin disease,
according to our knowledge, there is no data on H. pylori
infection and PV.
Superficial fungal infections of the skin are common
diseases in all parts of the world [13]. Pityriasis versicolor
is a noninflammatory superficial fungal infection of the
skin caused by fungi of the Malassezia type, that can lead
to social, emotional, and economic problems for patients
[14]. The diagnosis of PV is confirmed by the use of Wood’s
lamp, KOH examination under the microscope, and
fungal cultures, in addition to presence of characteristic
clinical changes [15–17]. Risk factors that can predispose
an individual to PV include humid environment,
malnutrition, and immunosuppression such as with HIV
or renal transplant disease, corticosteroid use [18,19].
Helicobacter pylori infection has been found to be
associated with mucosal inflammation due to infiltration
by monocytes and neutrophils in the gastric mucosa.
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Table 1. Demographic and laboratory characteristics of pityriasis versicolor and telogen
effluvium groups.
Characteristic

Pityriasis versicolor
(n = 27)

TE group
(n = 30)

P value

Age (years)

29.52 ± 12.76

29.20 ± 12.79

0.816

Height (m)

166.59 ± 8.92

159.11 ± 5.30

0.031

Body mass (kg)

70.07 ± 13.71

61.94 ± 11.51

0.816

BMI (m/kg )

25.18 ± 4.11

24.57 ± 5.09

0.648

Hb (g/dL)

14.26 ± 1.63

13.32 ± 1.26

0.022

WBC (×10 /L)

7.49 ± 1.60

7.02 ± 1.58

0.291

PLT (×109/L)

275.82 ± 79.56

248.30 ± 72.18

0.221

ALT (IU/L)

20.93 ± 14.95

18.11 ± 10.15

0.798

AST (IU/L)

22.07 ± 9.83

21.11 ± 4.54

0.660

Urea mg/dL

28.41 ± 6.79

24.89 ± 6.09

0.175

Creatinine mg/dL

0.91 ± 0.17

0.85 ± 0.08

0.421

2
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n: number of patients TE: Telogen effluvium
BMI: Body mass index
Table 2. Laboratory results of H. pylori and dyspepsia positivity in patients with pityriasis
versicolor and telogen effluvium.
PV* group

TE group

χ2 p*

OR

Dyspepsia positivity

19 (70.4%)

8 (26.7%)

0.001

2.48(1.3–4.6)

H. pylori positivity

18(66.6%)

10(33.3%)

0.040

1.67 (1.0–2.28)

CagA positivity

17(63.0 %)

17(56.7%)

0.788

1.13(0.69–1.85)

H. pylori IgG positivity

24(88.9%)

19(63.3%)

0.033

1.78(1.15–2.74)

*P ≤ 0.05 = Statistically significant. Chi‑square test was performed. OR: Odds ratio
PV: pityriasis versicolor TE: telogen effluvium.

Furthermore, translocation of CagA into gastric epithelial
cells causes elevated levels of proinflammatory cytokines
including tumour necrosis factor–α, interleukin (IL)-6, IL8, IL-10, and IL-17 [20,21]. Immune dysregulation due to
H. pylori infection can change the skin microenvironment
and might contribute to the tendency to PV.
In this study, we found that H. pylori IgG and UBT
positivity were significantly higher in patients with PV
than the control group, 1.78 and 1.67 times, respectively.
Furthermore, dyspepsia was present much more in patients
with PV compared to the control group. The odds ratio
for patients with PV for dyspepsia was 2.48. In this regard
it can be speculated that acute and chronic inflammation
due to previous H. pylori infection may lead to a tendency
to PV, and H. pylori could be a new etiologic factor for PV.
CagA strains of H. pylori are prone to more severe
gastrointestinal diseases as well as autoimmune systemic
diseases including idiopathic thrombocytopenic purpura,

Table 3. Odds ratio for dyspepsia, UBT, and H. pylori IgG
positivity.
Characteristic

OR

Dyspepsia positivity

2.48 (1.3–4.6)

H. pylori positivity

1.67 (1.0–2.28)

H. pylori IgG positivity

1.78(1.15–2.74)

OR: Odds ratio (minimum, maximum)
UBT: Urea breath test

autoimmune thyroiditis as well as vitiligo [2,22,23]. The
CagA protein stimulates the gastric epithelium to secrete
high levels of inflammatory cytokines such as IL-8,
macrophage inflammatory protein (MIP-1α), and IL1-β.
These cytokines have chemotactic activity on neutrophils,
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T lymphocytes, and other leukocytes [20]. We did not find
any relationship between H. pylori infection and PV in
terms of CagA positivity. In this regard, it can be speculated
that high CagA levels trigger autoimmunity rather than
immunosuppression. Therefore, it can be concluded that
CagA levels could be normal in patients with PV.
The UBT test, which has a specificity of 93%–100%
and a sensitivity of 88%–96%, allows the determination
of H. pylori status more precisely [24]. In this study,
we carried out the UBT test to provide better evidence
supporting whether active infection with H. pylori may
trigger PV or not. We detected that UBT positivity was
higher in patients with PV. H. pylori infection, which
secretes the VacA protein, affects macrophages and B- and
T-lymphocytes and leads to decreased IL-2 production
with the consequence of suppressed IL-2-mediated T
lymphocyte proliferation [20,21]. This finding may suggest
that active H. pylori infection, which can be shown by UBT,
may decrease proinflammatory cytokines and may lead to
immunosuppression.
In our study, the prevalence of H. pylori detected by
UBT was lower than the general population which can
be explained in several ways. Eighteen out of 27 patients
(66.6%) with PV and 10 out of 33 (33.3%) patients with TE
had H. pylori positivity. If patients with PV and TE were
considered totally, H. pylori was positive in 28 out of 57
(49%) patients presented to the dermatology clinic due to
PV and TE without dyspepsia as the main complaining.
In addition, the prevalence of H. pylori differs in terms of
the development of socioeconomic and infrastructure in
countries, cities as well as various regions of the same city.

The population participating in our study was one of the
highest socioeconomic cities in Turkey. Furthermore, it is
well established that as the levels of development increases
in a country, the prevalence of H. pylori decreases. Özden
et al. reported the prevalence of H. pylori as 78.5% in 1990
and 66.3% in 2000 [25]. This result is clearly related to the
improvement of the socio-economic level and infrastructure.
Therefore, we believe that the prevalence of H. pylori has
decreased significantly over time due to improvements in
socioeconomic status and infrastructure during the last 15
years. Lastly, according to our study, despite the fact that the
ratio of the H. pylori positivity was close to the prevalence
of the general population, this prevalence would be slightly
higher if the number of patients had higher.
Although previous studies mostly detected an
association between autoimmune skin disease and H. pylori
infection, there are few studies on H. pylori infection and
infectious skin diseases. In this study, we found a statistically
significant relationship between H. pylori infection and PV.
Therefore, H. pylori eradication could be considered in
PV patients concomitant with dyspepsia. The relationship
between H. pylori infection and PV should be supported
by further studies with a larger sample size. In addition,
new studies are required to clarify the effect of eradication
treatment on the clinical course of PV.
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